Amgen (AMGN) Completes Tender Offer for Outstanding Shares of Micromet
3/7/2012 10:04:51 AM
More...
|
Amgen (AMGN) Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering Period
3/5/2012 9:59:10 AM
More...
|
Buyout Offer for Micromet Triggers Shareholder-Claim Investigation by Goldfarb LLP Securities Attorneys
2/6/2012 9:30:56 AM
More...
|
Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab
1/9/2012 6:35:48 AM
More...
|
Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients
12/12/2011 7:49:18 AM
More...
|
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
12/5/2011 6:23:09 AM
More...
|
Micromet Initiates Global Phase 2 Trial of Blinatumomab in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
11/28/2011 10:25:44 AM
More...
|
Micromet to Present at the 2011 Piper Jaffray Health Care Conference
11/23/2011 10:11:26 AM
More...
|
Micromet Reports Third Quarter 2011 Financial Results
11/8/2011 7:18:33 AM
More...
|
Micromet to Report Blinatumomab Data at 2011 American Society of Hematology Annual Meeting
11/8/2011 7:12:52 AM
More...
|
|